Mariana de Souza Terron

Mariana de Souza Terron

Auto-generated profile, based on publicly available information

Mariana de Souza Terron

State University of Maringá

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2025 in Reviews in Medical Virology
Verified
Journal Article
Open access
KGKarla Larissa Trassi Ganaza‐Domingues
Karla Larissa Trassi Ganaza‐Domingues
ÁRÁquila Carolina Fernandes Herculano Ramos-Milaré
Áquila Carolina Fernandes Herculano Ramos-Milaré
DLDaniele Stéfanie Sara Lopes Lera-Nonose
Daniele Stéfanie Sara Lopes Lera-Nonose
ABAline Ávila Brustolin
Aline Ávila Brustolin
LOLarissa Ferreira de Oliveira
Larissa Ferreira de Oliveira
JTJorge Juarez Vieira Teixeira
Jorge Juarez Vieira Teixeira
Studies with strong scientific evidence have demonstrated that comorbidities are associated with fatal outcomes in patients with SARS‐CoV‐2 infection. To aggregate the findings of these studies and assess the magnitude of the effect of different chronic diseases on COVID‐19 mortality, we conducted a systematic review of reviews and meta‐analysis. Six databases were searched to retrieve systematic reviews with meta‐analysis published during the early years of the pandemic. Statistical analysis was performed using Stata v.12.0 software, and the risk ratio (RR) and odds ratio (OR), with a confidence interval of 95% (95% CI), were calculated. We selected 15 publications with 476 original articles and 2,135,888 patients. Our results indicated the following risk factors for COVID‐19 mortality: diabetes mellitus (RR = 1.95; 95% CI:1.41–2.49); hypertension (RR = 1.88; 95% CI:1.51–2.26); cancer (RR = 1.84; 95% CI:1.24–2.43); cardiovascular (RR = 2.14; 95% CI:1.66–2.63), cerebrovascular (RR = 2.43; 95% CI:2.15–2.72), kidney (RR = 2.39; 95% CI:1.36–3.42), pulmonary (RR = 1.98; 95% CI:1.48–2.47) and liver diseases (OR = 1.56; 95% CI:1.18–1.94); obesity (OR = 1.15; 95% CI:1.04–1.26); smoking habits (OR = 1.18; 95% CI:1.13–1.22); and the male sex (OR = 1.69; 95% CI:1.65–1.73). Evidence has confirmed that underlying chronic conditions, which involve an imbalance in the immune response, significantly increase the risk of COVID‐19 deaths.

5 December 2018 in Parasitology Research
Verified
Journal Article
Closed access
PDF file
MTMariana de Souza Terron-Monich
Mariana de Souza Terron-Monich
IDIZABEL GALHARDO DEMARCHI
IZABEL GALHARDO DEMARCHI
PSPollyanna Rina Ferreira da Silva
Pollyanna Rina Ferreira da Silva
ÁRÁquila Carolina Fernandes Herculano Ramos-Milaré
Áquila Carolina Fernandes Herculano Ramos-Milaré
ZGZilda Gazim
Zilda Gazim
MLMaria Valdrinez Campana Lonardoni
Maria Valdrinez Campana Lonardoni

15 April 2021 in Immunotherapy
Verified
Journal Article
Closed access
CMCamila Alves Mota
Camila Alves Mota
JOJully Oyama
Jully Oyama
MMMariana de Souza Terron Monich
Mariana de Souza Terron Monich
ABAline Ávila Brustolin
Aline Ávila Brustolin
JSJoão Vítor Perez de Souza
João Vítor Perez de Souza
TSThais Silveira
Thais Silveira
Aim: Current treatments for leishmaniases are not satisfactory, thus alternatives are needed. We searched for clinical trials with immunotherapeutic approaches for patients with leishmaniasis. Mate...

18 August 2026 in HLA
Verified
Journal Article
Closed access
PDF file
RSRaquel Rodrigues dos Santos
Raquel Rodrigues dos Santos
FMFernanda Pelisson Massi
Fernanda Pelisson Massi
BHBruna Karina Banin Hirata
Bruna Karina Banin Hirata
MTMariana de Souza Terron
Mariana de Souza Terron
LPLarissa Danielle Bahls Pinto
Larissa Danielle Bahls Pinto

27 August 2026 in HLA
Verified
Journal Article
Closed access
MMMariana Guimarães Barbosa de Medeiros
Mariana Guimarães Barbosa de Medeiros
FMFernanda Pelisson Massi
Fernanda Pelisson Massi
MTMariana de Souza Terron
Mariana de Souza Terron
Jeane Eliete Laguila VisentainerJeane Eliete Laguila Visentainer
Jeane Eliete Laguila Visentainer
LPLarissa Danielle Bahls Pinto
Larissa Danielle Bahls Pinto

13 October 2026 in Expert Review of Molecular Diagnostics
Verified
Journal Article
Closed access
GBGiovana Paola Zaccarias Bemvides
Giovana Paola Zaccarias Bemvides
RSRaquel Rodrigues dos Santos
Raquel Rodrigues dos Santos
MRMilena Eloisa Ribeiro
Milena Eloisa Ribeiro
MBMatheus Braga
Matheus Braga
DCDaniel Caligari
Daniel Caligari
Jeane Eliete Laguila VisentainerJeane Eliete Laguila Visentainer
Jeane Eliete Laguila Visentainer
1. Patients with hematological disorders and cancers are often treated with allogeneic hematopoietic stem cell transplantation (HSCT), sometimes the only chance for a cure [1]. Over time, molecular...